Suanne Nakajima, J.D.
Head of Intellectual Property
Senda Biosciences

Suanne has more than 15 years of experience in intellectual property in the biopharmaceutical industry. 

Prior to joining Senda Biosciences, Suanne served as Director, Intellectual Property Counsel at Alnylam Pharmaceuticals, where she developed and executed intellectual property strategies for Alnylam’s platforms and therapeutic candidates including ONPATTRO, GIVLARRI, OXLUMO and vutrisiran. She also supported litigation efforts involving the Alnylam platform intellectual property estate. Before joining Alnylam Pharmaceuticals, she was a patent agent at Elmore Patent Law Group, where she built intellectual property estates for numerous small size companies. 

Suanne began her career as a medicinal chemist, where she is an inventor on more than ten issued US patents. She obtained her BSc and MSc degrees in organic chemistry from the University of Calgary, and a law degree from Suffolk University Law School.